MSB 1.26% $1.00 mesoblast limited

Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel, page-6

  1. 2,813 Posts.
    lightbulb Created with Sketch. 1940
    Hopefully the AGM will clarify the stumbling and bumbling by the analysts on the call.

    Most positive take
    Clock starts from this new data being submitted- presume the rest of the BLA is going at the same time
    Heart partnerships WILL happen after the FDA meeting- no date set
    Back- commence USA Q2, Europe Q3

    Negative- Financials - drop in Temcell revenue.


    Reg
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.00
Change
0.013(1.26%)
Mkt cap ! $1.158B
Open High Low Value Volume
99.5¢ $1.02 98.5¢ $1.297M 1.291M

Buyers (Bids)

No. Vol. Price($)
19 140366 $1.00
 

Sellers (Offers)

Price($) Vol. No.
$1.01 57184 19
View Market Depth
Last trade - 11.51am 15/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.